US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

SRA

Serono (SRA)

Serono S A

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:SRA

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2011/01/17	17 : 32	PR Newswire (US)	Merck Serono and Domain Therapeutics Announce an Agreement to Develop Drugs for Parkinson's Disease	NYSE:SRA	Serono S A
2011/01/12	17 : 01	PR Newswire (US)	Brighter Futures in MS - Inspiring Short Film Premieres in Brussels	NYSE:SRA	Serono S A
2010/12/13	20 : 00	PR Newswire (US)	Merck Serono and San Raffaele Scientific Institute to Collaborate on Research in Neurodegenerative Diseases	NYSE:SRA	Serono S A
2010/11/26	16 : 00	PR Newswire (US)	Merck Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Mu	NYSE:SRA	Serono S A
2010/11/17	16 : 46	PR Newswire (US)	Merck Serono: Enrollment Completed for ORACLE MS Study of Cladribine Tablets in Patients at Risk of Developing MS	NYSE:SRA	Serono S A
2010/11/15	16 : 30	PR Newswire (US)	Merck Serono: Ready-to-Use Formulation of Recombinant Growth Hormone Saizen Recommended for Approval in Europe	NYSE:SRA	Serono S A
2010/11/04	15 : 00	PR Newswire (US)	Merck Serono Announces Top-Line Results of Long-Term Study of Safinamide as Add-on Treatment to Levodopa in Advanced Parkinson's	NYSE:SRA	Serono S A
2010/10/28	23 : 33	PR Newswire (US)	Merck Serono Sells Théramex to Teva for EUR 265 Million	NYSE:SRA	Serono S A
2010/10/25	18 : 19	PR Newswire (US)	Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First Clinical Signs of	NYSE:SRA	Serono S A
2010/10/15	22 : 30	PR Newswire (US)	Merck Serono to Introduce RebiDose(TM), the Rebif(R) Single Use Pre-filled Pen for Treatment of Multiple Sclerosis	NYSE:SRA	Serono S A
2010/10/13	16 : 00	PR Newswire (US)	Merck Serono: New Presentation of Cyanokit(R) Approved in Europe	NYSE:SRA	Serono S A
2010/10/11	15 : 00	PR Newswire (US)	Merck Serono Notified EMA of its Intention to Appeal CHMP Opinion on Cladribine Tablets in MS	NYSE:SRA	Serono S A
2010/10/11	14 : 30	PR Newswire (US)	Ablynx and Merck Serono Enter into Second Agreement To Co-Discover and Co-Develop Nanobodies (R)	NYSE:SRA	Serono S A
2010/08/03	19 : 38	PR Newswire (US)	Merck Serono Calls for Entries to Real MS - Your Story, a Global Competition to Raise Awareness of Multiple Sclerosis	NYSE:SRA	Serono S A
2010/07/28	16 : 05	PR Newswire (US)	Merck Serono: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS	NYSE:SRA	Serono S A
2010/07/12	15 : 00	PR Newswire (US)	Merck Serono's Cladribine Tablets for MS Approved in Russia	NYSE:SRA	Serono S A
2010/06/29	15 : 00	PR Newswire (US)	Merck Serono to Award Grant to Innovative Research Projects in Fertility	NYSE:SRA	Serono S A
2010/06/10	14 : 30	PR Newswire (US)	Merck Serono: Data on Safinamide to Be Presented at the 14th MDS Meeting	NYSE:SRA	Serono S A
2010/06/08	15 : 00	PR Newswire (US)	Merck Serono Resubmits U.S. Application for Cladribine Tablets as a Potential MS Therapy	NYSE:SRA	Serono S A
2010/05/26	17 : 00	PR Newswire (US)	Your Story, Your Voice, Your Achievements, Your Ideas ... This Is About Life, Real Life, Real MS	NYSE:SRA	Serono S A
2010/05/25	16 : 07	PR Newswire (US)	International Thyroid Awareness Week 2010 to Focus on Thyroid Disorders and Pregnancy	NYSE:SRA	Serono S A
2010/03/31	16 : 00	PR Newswire (US)	Data from Merck Serono's Multiple Sclerosis Portfolio to be Presented at the 62nd Annual Meeting of the American Academy of Neur	NYSE:SRA	Serono S A
2008/10/10	14 : 00	PR Newswire (US)	Merck Serono Named as a Top Employer by Science Magazine	NYSE:SRA
2007/07/06	18 : 01	PR Newswire (US)	Squeeze Out of Merck Serono Shares Successfully Completed	NYSE:SRA
2007/04/27	07 : 56	PR Newswire (US)	HealthShares(TM) Announces Changes to the HealthShares(TM) Dermatology & Wound Care, Emerging Cancer, and Composite Indexes	NYSE:SRA	Serono S A
2007/04/06	00 : 00	PR Newswire (US)	Merck Serono S.A. to Voluntarily Delist and Deregister its Bearer Shares and American Depositary Shares (Evidenced by American D	NYSE:SRA	Serono S A
2007/03/21	19 : 08	PR Newswire (US)	Merck Initiates Squeeze Out Procedure for Shares of Merck Serono S.A.	NYSE:SRA
2007/03/21	16 : 15	PR Newswire (US)	Merck Serono Confirms Previously Announced 2006 Figures	NYSE:SRA
2007/03/01	15 : 15	PR Newswire (US)	Merck KGaA Announces Serono Preliminary Figures for 2006	NYSE:SRA
2007/02/28	18 : 54	PR Newswire (US)	Merck Serono S.A. Preliminary Q4/FY 06 Results - March 1	NYSE:SRA	Serono S A

Showing the most relevant articles for your search:NYSE:SRA

1 2 3 4 5 次へ >>

NLBNPIT203M0 20241220 450

NLBNPIT1XMA8 20240920 1.1

Societe Generale Effekten

NLBNPIT20B41 20991231 28...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約